Covington & Burling Sample Contracts

CREDIT AGREEMENT Dated as of November 18, 2011, Among AVNET, INC. And CERTAIN OTHER SUBSIDIARIES as Borrowers, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, THE ROYAL BANK OF SCOTLAND PLC, BNP PARIBAS, THE BANK OF NOVA SCOTIA and THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., as Syndication Agents, and the Other Lenders Party Hereto MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, BNPP SECURITIES CORP., THE BANK OF NOVA SCOTIA, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. And RBS SECURITIES INC. As Joint Lead Arrangers and Joint Bookrunners (November 22nd, 2011)

This CREDIT AGREEMENT (Agreement) is entered into as of November 18, 2011, among AVNET, INC., a New York corporation (the Company), each other Subsidiary of the Company party hereto pursuant to Section 2.14 (each such other Subsidiary, a Designated Borrower and, together with the Company, the Borrowers and, each a Borrower), each lender from time to time party hereto (collectively, the Lenders and individually, a Lender), and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer.

Siberian Energy Group Inc. – Contract (December 2nd, 2005)

Exhibit 10.1 DATED November 9, 2005 (1) OOO ZAURALNEFTEGAZ and (2) CASPIAN FINANCE LIMITED LOAN AGREEMENT Covington & Burling Registered Foreign Lawyers and Solicitors - London 265 Strand London WC2R 1BH THIS LOAN AGREEMENT is made on November 9, 2005. PARTIES: OOO ZAURALNEFTEGAZ, a limited liability company incorporated under the laws of - ------------------- the Russian Federation under the main state registration number (ORGN) 1024500513950, located at 27 Lenin Street, Kurgan, 640000, Kurgan Oblast, Russian Federation ("ZNG"); and CASPIAN FINANCE LIMITED, a company incorporated in England and Wales under - ------------------------- company number 0

Fidelity National Finl Inc – Contract (September 20th, 2005)
Telular Corporation – Contract (September 6th, 2005)

EXHIBIT 10.1 PURCHASE AGREEMENT ------------------ THIS PURCHASE AGREEMENT ("Agreement") is made as of the 2nd day of September, 2005 by and among Telular Corporation, a Delaware corporation (the "Company"), and the Investors set forth on the signature pages affixed hereto (each an "Investor" and collectively the "Investors"). RECITALS A. The Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the provisions of Regulation D ("Regulation D"), as promulgated by the U.S. Securities and Exchange Commission (the "SEC") under the Securities Act of 1933, as amended; and B. The Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors, upon the terms and conditions stated in this Agreement, (i) an aggre

Motient – Contract (May 11th, 2005)

EXHIBIT 10.1 PURCHASE AGREEMENT (this "AGREEMENT"), dated as of May 11, 2005, by and between TerreStar Networks Inc., a Delaware corporation ("TERRESTAR"), and Motient Ventures Holding Inc., a Delaware corporation (the "PURCHASER"). -------------------------------------------------- INTRODUCTION ------------ WHEREAS, pursuant to the terms and subject to the conditions set forth in this Agreement, the Purchaser desires to make an equity investment in TerreStar; WHEREAS, immediately prior to the Closing (as defined in Section 2.1), certain Rights to Receive Common Shares of TerreStar, dated as of December 20, 2004, as amended (the "RIGHTS"), held by the limited partners (or affiliates of such limited partners) of Mobile Satellite Ventures LP ("MSV LP") were exchanged for shares of common stock, par value $0.001

VaxGen – Contract (April 11th, 2005)

Exhibit 10.1 - -------------------------------------------------------------------------------- VAXGEN, INC. $31,500,000 5 1/2% Convertible Senior Subordinated Notes due 2010 NOTE PURCHASE AGREEMENT March 30, 2005 - -------------------------------------------------------------------------------- VAXGEN, INC. NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT, INCLUDING ANNEX I HERETO (this "Agreement") is made as of the 30(th) day of March 2005 by and among VAXGEN, INC. (the "Company"), a Delaware corporation, with its principal offices at 1000 Marina Blvd., Suite 200, Brisbane, California, and ____________________ (the "Purchaser"). In consideration of the mutual covenants contained in this Agreement, and other good and valuable con

Medarex – Contract (September 18th, 2002)
Impco Technologies – Contract (May 10th, 2002)

Percentage Jurisdiction Subsidiary Owned by IMPCO of Formation - ---------------------------------------------------------------------------------- Quantum Fuel Systems Technologies Worldwide, Inc. 100% Delaware IMPCO Technologies B.V. 51% Netherlands Grupo I.M.P.C.O. Mexicano, S. de R.L. de C.V. 90% Mexico IMPCO Technologies, Pty. Limited 100% Australia IMPCO Tech Japan K.K 100% Japan Minda IMPCO Technologies, Ltd. 60% India Minda IMPCO Limited 40% India IMPCO Fuel Systems (NSW) Pty. Ltd. 51% Australia IMPCO Technologies (SA) Pty. Ltd. 100% Australia IMPCO Technologies (NSW) Pty. Ltd.

Contract (April 11th, 2002)

Number of Shares of Amount of Investor Series D Preferred Stock Investment - -------- ------------------------ ---------- Charlesbank Equity Fund IV, Limited 8,100,215 $24,300,645 Address for notices: c/o Charlesbank Capital Partners, LLC 600 Atlantic Avenue Boston, Mass. 02210-2203 Attention: Mark A. Rosen and Tami E. Nason Fax (617) 619-5402 Charlesbank Coinvestment 5,000 $ 15,000 Partners Fund Address for notices: c/o Charlesbank Capital Partners, LLC 600 Atlantic Avenue Boston, Mass. 02210-2203 Attention: Mark A. Rosen and Tami E. Nason Fax (617) 619-5402 The 1818 Mezzanine Fund, L. P. Address for 1,532,377 $ 4,597,131 notic

Epoch Holding Corporation – Stock Purchase Agreement (February 2nd, 2001)
Andrx – Credit Agreement (January 17th, 2001)
Mediconsult.Com Inc – Credit Agreement (January 16th, 2001)
Caliber Learning Network Inc – Page ARTICLE I. SERIES A-2 DEMAND REGISTRATIONS.............................. 2 1.1 Requests for Registration by Series A-2 Holders............. 2 1.2 Limitations on Series A-2 Demand Registrations.............. 2 1.3 Effective Registration Statement............................ 2 1.4 Priority on Series A-2 Demand Registrations................. 3 1.5 Selection of Underwriters................................... 3 1.6 Priority of Series A-2 Demand Registrations................. 3 ARTICLE 1A. SERIES B PURCHASER DEMAND REGISTRATIONS...................... 3 1A.1 Requests for Registration by Series B (January 3rd, 2001)

-ii- AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This Amended and Restated Registration Rights Agreement is dated as of December 29, 2000, among Caliber Learning Network, Inc., a Maryland corporation (the "Company"), Fleming US Discovery Fund III, L.P., Fleming US Discovery ------- Offshore Fund III, L.P. and Robert Fleming Nominees Limited (collectively, the "Series A-2 Purchasers"), and Sylvan Ventures LLC, a Maryland limited liability --------------------- company ("Sylvan"), Fleming US Discovery Fund III, L.P. and Fleming US Discovery ------ Offshore Fund III, L.P. and such other purchasers as may from time to time purchase the Series B Preferred (as defined below) directly from the Company (the "Future Investors") (each of the foregoing parties other than the Company and the Series A-2 Purchasers being referred to individually as a "Series B -------- Purchaser" an

Antex Biologics Inc – Omnibus Agreement (October 28th, 1999)
Page ---- ARTICLE I DEFINITIONS................................................ .........................1 ARTICLE II PURCHASE AND SALE OF THE COMPANY SHARES.............................................6 2.1 Basic Transaction...................................................................6 2.2 Purchase Price......................................................................6 (A) Generally...................................................................6 (B) Consideration in the Form of Buyer Shares...................................6 (C) Payment.......................................... (January 5th, 1999)

LIST OF EXHIBITS Exhibit A June 30, 1998 Balance Sheet Exhibit B-1 Officer's Certificate Exhibit B-2 Secretary's Certificate Exhibit C General Release LIST OF SCHEDULES Schedule 2.2(b) Cash and Stock Allocation Schedule Schedule 2.3 Funded Indebtedness Schedule 2.4 Example of Purchase Price Adjustments and Funding Mechanics Schedule 3.1 Company's Capitalization Schedule Schedule 3.4A Certificate and Bylaws Schedule 3.4B Due Organization Schedule 3.5 Subsidiaries Schedule 3.7 Financial Statements Schedule 3.8A Certain Actions Schedule 3.8B Material Changes Schedule 3.9 Properties Schedule 3.10 Licenses and Permits Schedule 3.11

Regenerx Biopharmaceuticals – Contract (January 13th, 1998)

APPLICATION PATENT SUBJECT COUNTRY NUMBER NUMBER APPLICANT(S) - ------------------------------------------------------------------------------------------- Solid Phase Austria 86302731 E 91 130 B Alpha Process for Belgium 86302731 0 200 404 Alpha Synthesizing Canada 506,495 1,271,300 Alpha Peptides EPO 86302731.4 0200404 Alpha Germany 86302731 36 88 632 T2 Alpha Israel 78479 78479 Alpha Israel 97297 97297 Alpha Italy 86302731 0 200 404 Alpha Luxembourg 863

Asset Exchange Agreement (September 18th, 1997)
Unigene Laboratories – Contract (August 4th, 1997)

ANNEX D W-L Marketing Projections Unigene Project Oral Calcitonin Forecasts $ Millions Treatment Only - ------------------------------------------------------------------------------------------------------------------------------------ Years YEAR 1 YEAR 2 YEAR 3 YEAR 4 YEAR 5 YEAR 6 YEAR 7 YEAR 8 After Launch - ------------------------------------------------------------------------------------------------------------------------------------ U.S. $[ ] $[ ] $[ ] $[ ] $[ ] $[ ] $[ ] $[ ] - ------------------------------------------------------------------------------------------------------------------------------------ Europe [ ] [ ] [ ] [ ] [ ] [ ]

B M J Financial Corp – Agreement and Plan of Merger (September 19th, 1996)